YOLFTbeta
46

LAMEDITECH Co., Ltd.

462510 · KQ · Healthcare / Medical Devices

2,135.00KRW-5.00 (-0.23%)

Price History

Full chart

Market Stats

Previous Close2,140.00
Open2,120.00
Day Range2,090.00 – 2,255.00
52-Week Range2,290.00 – 8,400.00
Volume98.47K
Market Cap31.21B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.32
50-Day Avg2,839.00
200-Day Avg4,257.85

About

Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system; and Ray-Vet, a UVB light irradiation therapy system designed to treat inflammatory skin diseases and various auto-immune diseases in pets and animals. The company was founded in 2012 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • Employees0
  • Headquarters#1002, ACE HighEnd Tower, Seoul, South Korea, Korea
  • Websitehttps://lameditech.com

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue2.06B2.92B6.58B7.19B
Growth (%)-+41.95%+125.37%+9.28%
Cost of Revenue1.77B2.02B4.22B4.04B
Gross Profit284.81M899.43M2.36B3.15B
Gross Margin13.85%30.82%35.84%43.79%
Operating Expense3.63B4.43B12.02B14.99B
Operating Income-3.34B-3.53B-9.66B-11.84B
Operating Margin-162.65%-120.81%-146.90%-164.78%
EBITDA-3.19B-7.03B-8.96B-10.56B
EBITDA Margin-155.13%-240.96%-136.22%-146.89%
Net Income-4.43B-8.30B-9.48B-11.37B
Net Income Margin-215.50%-284.58%-144.20%-158.15%
R&D1.26B765.30M1.47B1.66B
R&D as % of Total Revenue61.30%26.22%22.29%23.16%
Interest Expense1.01B976.99M59.72M214.72M
Interest Expense % of Total Revenue48.93%33.48%0.91%2.99%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets7.86B11.28B22.35B25.20B
Total Liabilities19.61B2.73B3.19B16.78B
Total Equity-11.75B8.55B19.15B8.42B
Cash16.41M14.87M17.36M5.25B
Net Debt---1.91B

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.39B-3.76B-9.81B-13.16B
Investing Cash Flow-383.58M-4.16B-4.32B-
Financing Cash Flow1.57B6.29B19.69B-
Capital Expenditure314.36M156.35M4.39B2.17B
Free Cash Flow-3.70B-3.92B-14.19B-15.33B
FCF to OCF109.28%104.16%144.74%116.51%

Earnings

Report DateJun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------
EPS Actual-318.09-268.68-321.37-318.04-294.35-343.69-342.51-328.98-94.15
Surprise---------
Timing---------

Key Statistics & Ratios

Market Cap31.21B
Enterprise Value27.76B
Trailing P/E0.00
Forward P/E0.00
Price / Sales5.61
Price / Book4.88
Revenue (TTM)5.56B
Gross Profit (TTM)2.22B
EBITDA-10.20B
Profit Margin-175.40%
Operating Margin-149.32%
Return on Equity-102.23%
Return on Assets-33.22%
Shares Outstanding8.80M
Shares Float4.74M
Beta0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%